EUVIMEDEUVIMED entdecken
Crossref

Anti-receptor activator nuclear factor κ-B ligand (anti-RANKL) as an antiresorptive agent for renal failure osteoporotic patient

Mansoor Karimifar, Mozhgan Karimifar

Journal of Parathyroid Disease · 2017

DOI: 10.15171/jpd.2018.12 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Parathyroid Disease, 2017. Verfasst von Mansoor Karimifar und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Karimifar, M., & Karimifar, M. (2017). Anti-receptor activator nuclear factor κ-B ligand (anti-RANKL) as an antiresorptive agent for renal failure osteoporotic patient. Journal of Parathyroid Disease. https://doi.org/10.15171/jpd.2018.12

Vancouver

Karimifar M, Karimifar M. Anti-receptor activator nuclear factor κ-B ligand (anti-RANKL) as an antiresorptive agent for renal failure osteoporotic patient. Journal of Parathyroid Disease. 2017. doi:10.15171/jpd.2018.12

BibTeX
@article{Karimifar2017,
  author = {Karimifar, Mansoor and Karimifar, Mozhgan},
  title = {Anti-receptor activator nuclear factor κ-B ligand (anti-RANKL) as an antiresorptive agent for renal failure osteoporotic patient},
  journal = {Journal of Parathyroid Disease},
  year = {2017},
  doi = {10.15171/jpd.2018.12}
}
Kostenlos starten →